Beyond their anti-inflammatory effects, these therapies improve insulin sensitivity and lipid metabolism, addressing critical aspects of diabetes management and reducing cardiovascular risk [90,91,92,93,94,95]. This evidence concerns the gene INS and diabetes mellitus.